Consequently, FADS2 knockdown plasmids were transfected into 5637 and BIU‐87 cells to establish bladder cancer cells with reduced FADS2 expression, and the transfection efficiency was confirmed (Figure 3B, S1B). The gene discussed is FADS2; the disease is urinary bladder cancer.